RETRACTED: Attenuation of aortic injury by ursolic acid through RAGE-Nox-NFκB pathway in streptozocin-induced diabetic rats (Retracted Article)

被引:39
作者
Xiang, Min [2 ]
Wang, Jianmei [1 ]
Zhang, Yaqin [2 ]
Ling, Jing [1 ]
Xu, Xiaoyue [3 ]
机构
[1] Suzhou Hlth Coll, Dept Pharm, Suzhou 215009, Peoples R China
[2] Suzhou Hlth Coll, Biotechnol Ctr, Suzhou 215009, Peoples R China
[3] Henan Prov Inst Food & Drug Control, Dept Pharmacol, Zhengzhou 450003, Peoples R China
关键词
NF-kappa B; Oxidative stress; p22phox; RAGE; Ursolic acid; Vascular complications; GLYCATION END-PRODUCTS; SUPEROXIDE-PRODUCTION; OLEANOLIC ACID; NADPH OXIDASE; CARDIOVASCULAR-DISEASE; NADH/NADPH OXIDASE; ENDOTHELIAL-CELLS; HYPERTENSIVE-RATS; GENE-EXPRESSION; RECEPTOR RAGE;
D O I
10.1007/s12272-012-0513-0
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Vascular complications are the leading causes of morbidity and mortality in diabetes mellitus (DM). The RAGE (receptor for advanced glycation end products)-NADPH oxidase-NF-kappa B signal transduction pathway plays an important role in the development of oxidative stress-related vascular complications in DM. Ursolic acid (UA), a pentacyclic triterpenoid derived from plants, has been reported to have multiple pharmacological effects, including a potent antioxidant activity. This study aimed to investigate both the effect of UA on aortic injury in streptozotocin (STZ)-induced diabetic rats and the drug's mechanism of action. STZ-induced diabetic animals were randomized in one of the following 4 groups: no treatment (diabetic model group), aminoguanidine (AG, 100 mg/kg), high-dose UA (50 mg/kg), and low-dose UA (25 mg/kg). A non-diabetic control group was followed concurrently. After 8 weeks, the diabetic model rats exhibited: severe aortic arch injury, histologically elevated serum glucose, fructosamine, and glycosylated hemoglobin; and accumulation of advanced glycation end products (AGEs) in the arota. In addition, the levels of RAGE protein, transcription factor NF-kappa B p65, and the p22phox subunit of NADPH oxidase were increased, as were the serum levels of malondialdehyde and tumor necrosis factor-alpha (TNF-alpha; p < 0.01 vs control), suggesting that the mechanisms of oxidative stress contributed to vascular injury in the diabetic model group. In contrast, rats treated with UA (50 mg/kg) had a markedly less vascular injury and significantly improved biochemical parameters. Oxidative balance was also normalized in the UA-treated rats, and a marked reduction in the levels of RAGE and p22phox paralleled the reduced activation of NF-kappa B p65 and TNF-alpha (p < 0.01 and p < 0.05, respectively, vs diabetic model). These findings suggest that UA may suppress oxidative stress, thus blunting activation of the RAGE-NADPH oxidase-NF-kappa B signal transduction pathway, to ameliorate vascular injury in the STZ-induced DM rats.
引用
收藏
页码:877 / 886
页数:10
相关论文
共 45 条
[1]
Advanced glycation endproducts - role in pathology of diabetic complications [J].
Ahmed, N .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) :3-21
[2]
Effects of glucose intolerance on myocardial function and collagen-linked glycation [J].
Avendano, GF ;
Agarwal, RK ;
Bashey, RI ;
Lyons, MM ;
Soni, BJ ;
Jyothirmayi, GN ;
Regan, TJ .
DIABETES, 1999, 48 (07) :1443-1447
[3]
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[4]
IDENTIFICATION OF THE MAJOR SITE OF APOLIPOPROTEIN-B MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS BLOCKING UPTAKE BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR [J].
BUCALA, R ;
MITCHELL, R ;
ARNOLD, K ;
INNERARITY, T ;
VLASSARA, H ;
CERAMI, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10828-10832
[5]
Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes [J].
Chandra, D ;
Jackson, EB ;
Ramana, KV ;
Kelley, R ;
Srivastava, SK ;
Bhatnagar, A .
DIABETES, 2002, 51 (10) :3095-3101
[6]
Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes [J].
Figarola, James L. ;
Shanmugam, Narkunaraja ;
Natarajan, Rama ;
Rahbar, Samuel .
DIABETES, 2007, 56 (03) :647-655
[7]
p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats [J].
Fukui, T ;
Ishizaka, N ;
Rajagopalan, S ;
Lauren, JB ;
Capers, Q ;
Taylor, WR ;
Harrison, DG ;
deLeon, H ;
Wilcox, JN ;
Griendling, KK .
CIRCULATION RESEARCH, 1997, 80 (01) :45-51
[8]
AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice [J].
Gao, Xue ;
Zhang, Hanrui ;
Schmidt, Ann Marie ;
Zhang, Cuihua .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 295 (02) :H491-H498
[9]
Advanced glycation end products - Sparking the development of diabetic vascular injury [J].
Goldin, Alison ;
Beckman, Joshua A. ;
Schmidt, Ann Marie ;
Creager, Mark A. .
CIRCULATION, 2006, 114 (06) :597-605
[10]
Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways [J].
Guha, M ;
Bai, W ;
Nadler, JL ;
Natarajan, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) :17728-17739